Table 2.

Distributional summaries of baseline pEGFR and total EGFR values by randomization group

Erlotinib dose
Characteristic25 mg (N = 14)50 mg (N = 14)100 mg (N = 14)
pEGFR in normal tissue
 Median8,433.96,938.712,098.2
 Mean (SD)14,004.2 (10,935.0)8,802.4 (6,935.6)16,673.3 (14,344.9)
 Range1,491.0–33,325.3112.5–28,728.24,892.9–39,215.4
pEGFR in ACF tissue
 Median7,959.06,612.57,450.7
 Mean (SD)12,729.1 (9,942.8)5,868.0 (3,090.9)10,528 (10,150.4)
 Range2,707.0–39,617.1168.3–10,955.3517.2–40,051.7
Total EGFR in normal tissue
 Median7,359.311,927.612,415.2
 Mean (SD)8,840.7 (6,824.7)13,285.2 (8,311.4)14,003.4 (7,587.1)
 Range26.0–26,333.3122.0–27,957.64,892.9–36,742.6
Total EGFR in ACF tissue
 Median9,342.28,560.46,623.2
 Mean (SD)10,300.7 (5,758.0)10,212.4 (7,473.4)9,507.5 (9,780.9)
 Range23.5–20,579.029.3–28,622.7280.2–36,132.3